 |
Previous Article | Next Article 
The Journal of Neuroscience, May 1, 2000, 20(9):3319-3327
Cuneiform Neurons Activated during Cholinergically Induced Active
Sleep in the Cat
Inés
Pose2,
Sharon
Sampogna1,
Michael
H.
Chase1, and
Francisco R.
Morales1, 2
1 Department of Physiology and the Brain Research
Institute, University of California at Los Angeles, Los Angeles,
California 90095, and 2 Departamento de Fisiología,
Facultad de Medicina, Montevideo 11800, Uruguay
 |
ABSTRACT |
In the present study, we report that the cuneiform (Cun) nucleus, a
brainstem structure that before now has not been implicated in sleep
processes, exhibits a large number of neurons that express c-fos during carbachol-induced active sleep
(AS-carbachol). Compared with control (awake) cats, during
AS-carbachol, there was a 671% increase in the number of neurons that
expressed c-fos in this structure. Within the Cun
nucleus, three immunocytochemically distinct populations of neurons
were observed. One group consisted of GABAergic neurons, which
predominantly did not express c-fos during AS-carbachol.
Two other different populations expressed c-fos during
this state. One of the Fos-positive (Fos+)
populations consisted of a distinct group of nitric oxide synthase (NOS)-NADPH-diaphorase (NADPH-d)-containing neurons; the
neurotransmitter of the other Fos+ population
remains unknown. The Cun nucleus did not contain cholinergic, catecholaminergic, serotonergic, or glycinergic neurons. On the basis
of neuronal activation during AS-carbachol, as indicated by
c-fos expression, we suggest that the Cun nucleus is
involved, in an as yet unknown manner, in the physiological expression
of active sleep. The finding of a population of NOS-NADPH-d containing neurons, which were activated during AS-carbachol, suggests that nitrergic modulation of their target cell groups is likely to play a
role in active sleep-related physiological processes.
Key words:
cuneiform nucleus; REM sleep; brainstem; immunohistochemistry; Fos; nitric oxide
 |
INTRODUCTION |
Active sleep (AS) is a complex
behavioral state that is comprised of diverse physiological processes
(Steriade and McCarley, 1990 ; Jones, 1991 ) (for review, see Siegel,
1994 ; Rye 1997 ). Among the distinguishing physiological characteristics
of this state are muscular atonia, EEG desynchronization,
ponto-geniculo-occipital (PGO) waves, and rapid eye movements.
There is evidence that many of these processes are initiated and/or
regulated by brainstem structures. The activity of cholinergic neurons
in the laterodorsal tegmental (LDT) and pedunculo-pontine tegmental
(PPT) nuclei appears to be critical for the generation of AS (Steriade
and McCarley, 1990 ; Jones, 1991 ; Hobson, 1992 ; Rye, 1997 ). For example,
the injection of cholinergic agonists into cholinoceptive structures in
the rostral pontine tegmentum triggers a state that is similar in many
aspects to naturally occurring AS (George et al., 1964 ; Baghdoyan et
al., 1987 , 1989 ; Morales et al., 1987 ; Vanni-Mercier et al., 1989 ).
This cholinergically induced AS-like state (AS-carbachol) has also been
used to explore the neurophysiological basis of AS and to identify
neuronal populations that are involved in the generation and
maintenance of this state (Baghdoyan et al., 1989 ; Shiromani et al.,
1992 ; Shuman et al., 1995 ; Xi et al., 1997 ; Capece et al., 1998 ;
Morales et al., 1999 ).
The expression of the proto-oncogene c-fos, detected by the
immunocytochemical visualization of its protein product Fos, has been
used as a marker of neuronal activity (for review, see Herrera and
Robertson, 1996 ; Chaudhuri, 1997 ). Since the development of these techniques, we (Yamuy et al., 1993 , 1995 , 1998 ; Morales et al.,
1999 ) and others have used the expression of c-fos to identify populations of neurons that are activated during AS
(Merchant-Nancy et al., 1992 ; Shiromani et al., 1992 ; Maloney et al.,
1999 ).
During the course of anatomical studies of the brainstem, we
consistently observed that larger number of neurons within the cuneiform (Cun) nucleus expressed c-fos during AS-carbachol
than during wakefulness. This finding is important, because the Cun nucleus has not been implicated previously in any of the physiological processes that occur during AS (for review, see Sakai, 1988 ; Steriade and McCarley, 1990 ; Jones, 1991 ; Hobson, 1992 ; Siegel, 1994 ; Rye, 1997 ).
In the present work, we describe the pattern of c-fos
expression in this brainstem nucleus. The present results confirm our preliminary observations and provide new evidence of the
neurotransmitter phenotype of cells within this structure. A novel
subpopulation of noncholinergic Cun neurons that contain nitric oxide
synthase (NOS) was found. Because these cells exhibited robust
c-fos expression during AS-carbachol, we suggest that they
participate in the nitrinergic modulation of their target neurons
during this state.
 |
MATERIALS AND METHODS |
Eleven adult cats, weighing between 3.0 and 3.5 kg, were used in
the present study. Five animals were studied after prolonged periods of
AS-carbachol (experimental animals); six cats were kept awake for
control periods (control animals).
Surgical procedures
All experimental procedures were conducted in accordance with
the Guide for the Care and Use of Laboratory Animals (Ed 7) and approved by the Chancellor's Animal Research Committee of the
University of California at Los Angeles for the protection of research
subjects. The surgical procedures to prepare "chronic" cats for
state recordings and the delivery of substances within the brainstem
have been described previously (Morales et al., 1999 ). Two weeks after
surgery, the cats were adapted to a head-restraining device until they
exhibited episodes of naturally occurring sleep.
Experimental procedures
Experimental animals. During the sleep studies, the
EEG, EMG, and electro-oculographic activity were recorded. After a
baseline recording period of 1 hr, the cannula of a 1 µl Hamilton
syringe that was filled with a solution of carbachol (88 mM, 16 µg in 1 µl of saline) was lowered
through an access hole in the occipital bone to inject carbachol at the
following stereotaxic coordinates: posterior 3.0, lateral 1.3, vertical
3.5 (Berman, 1968 ). Five cats were injected with 0.1 µl of this
solution. After a 2 hr recording session, the animals were
killed with an overdose of sodium pentobarbital (60 mg/kg,
i.p.).
Control animals. In previous work (Morales et al., 1999 ), we
compared data from AS-carbachol cats with those from animals in quiet
wakefulness. In the present report, we examined, as before, two control
cats in which the same procedures were followed, except that 0.1 µl
of saline was injected instead of carbachol. Four additional control
animals, which were awake, were included in the present study. Two of
these animals were maintained in quiet wakefulness by gentle
stimulation of the skin when the cats fell asleep. One control animal
was continuously aroused by tactile stimulation of the face and
whiskers. The remaining control cat was brought from the vivarium into
a laboratory room in which it was allowed to run freely for 2 hr. It
spent the free time in a state of arousal, during which time it
explored the environment. It was then anesthetized and killed. Because
there was no statistically significant difference in the number of
Fos-positive (Fos+) cells in the
Cun nucleus between the different groups of control animals, the data
from these cats were pooled to compare them with data from AS-carbachol animals.
While deeply anesthetized with sodium pentobarbital, all animals were
perfused transcardially with 1 l of saline, followed by 2.5 l
of a solution of 4% paraformaldehyde, 15% saturated picric acid, and
0.25% glutaraldehyde in 0.1 M phosphate buffer at pH 7.4. The brainstem was removed and immersed for a 24 hr post-fixation period
in a solution consisting of 2% paraformaldehyde and 15% saturated
picric acid in 0.1 M phosphate buffer at pH 7.4. After post-fixation, the tissue was kept in a solution of sucrose (30%) in
0.1 M phosphate buffer at pH 7.4.
Forty-eight to 72 hr later, the brainstem was frozen and cut into
15-µm-thick sections using a Reichert-Jung cryostat. As each section
was cut, it was placed in one well of a 36 well tray containing a
buffered solution [0.1 M PBS containing 0.3% Triton X-100
and 0.1% sodium azide (PBST-azide); note that Triton was omitted in those wells assigned for GABA immunocytochemistry]. The
first section obtained was placed in well 1 of the set, and consecutive
sections were placed in consecutive wells in serial order. Section 37 was placed in well 1, and the procedure was repeated until the entire
brainstem was sectioned. Using this method, each well contained a
sample of the entire brainstem wherein each section corresponded to a
cut 540 µm apart from the succeeding section (15 × 36). The
sections contained in different wells were then processed using
different antibodies.
Fos immunocytochemistry
Sections were processed for Fos immunostaining using a
polyclonal rabbit antibody (Fos Ab5; Oncogene Research Products,
Calbiochem, La Jolla, CA). The free-floating sections were incubated
overnight in this antiserum at a dilution of 1:20,000 in PBST-azide.
The sections were then rinsed in PBST for 30 min and incubated for 90 min in biotinylated donkey anti-rabbit IgG diluted 1:300 containing 1.5% normal donkey serum. After rinsing for 30 min, the sections were
incubated for 90 min in ABC complex (Vector Laboratories, Burlingame,
CA) at a dilution of 1:200. Peroxidase activity was visualized by
reacting the sections with 0.02% diaminobenzidine tetrahydrochloride
and 0.015 hydrogen peroxide in 50 ml of 50 mM Tris-buffered
saline, pH 7.5, for 15-30 min.
Neurotransmitter phenotype
Sections were treated for labeling of one of the following
transmitters or transmitter-related enzymes: choline acetyltransferase (ChAT), tyrosine hydroxilase (TH), glutamate, GABA, glutamic acid decarboxylase (GAD), glycine, serotonin (5-HT), and NOS.
NADPH-diaphorase (NADPH-d) chemical activity was examined using nitro
blue tetrazolium (NBT).
For ChAT, TH, 5-HT, GAD, and NOS immunocytochemistry, free-floating
sections were incubated overnight in one of the following: polyclonal
antiserum directed against ChAT (dilution 1:2000; Chemicon, Temeluca,
CA), TH (dilution 1:5000; Pel-Freeze Biologicals, Rogers, AR), 5-HT
(dilution 1:10000; Incstar), GAD (dilution 1:6000; Chemicon), or NOS
(dilution: 1:500; neuronal isoform; Accurate Chemicals, Westbury, NY).
After rinsing in PBST, the tissue was incubated for 90 min in their
respective secondary antibody at a dilution of 1:300 for ChAT and TH,
1:1000 for 5-HT, 1:200 for GAD, and 1:500 for NOS. The sections were
then rinsed in PBST and treated with the ABC complex (Vector
Laboratories standard Elite kit). Peroxidase activity was visualized by
reacting the sections with 0.02% diaminobenzidine tetrahydrochloride
(Sigma, St. Louis, MO) and 0.015 hydrogen peroxide in 50 ml of 50 mM Tris-buffered saline, pH 7.6 for 15-30 min.
For GABA immunoreactivity, an antibody to GABA conjugated to keyhole
limpet hemocyanin with glutaraldehyde (dilution 1:3500; Protos-Biotech
Corp., New York, NY) was used. Similar procedures as those described
above were followed afterwards. The dilution of the biotinylated donkey
anti-guinea pig secondary antibody was 1:300 and that of the ABC
complex was 1:200.
For glutamate immunoreactivity, a mouse monoclonal antibody to
glutamate conjugated to keyhole limpet homocystein with glutaraldehyde (dilution 1:500; Diasorin, Stillwater, MN) was used. The dilution of
the biotinylated donkey anti-mouse secondary antibody was 1:200 and
that of the ABC complex was 1:200.
For glycine immunoreactivity, a rabbit polyclonal antibody against
glycine-conjugated t-thyroglobulin with glutaraldehyde (1:500;
Chemicon) were used. The dilution of the biotinylated donkey anti-mouse
secondary antibody was 1:200 and that of the ABC complex was 1:200.
To detect NADPH-d chemical activity, sections were incubated in a
solution of 0.1 M PBS, pH 7.4, 0.3% Triton X-100, 0.1 mg/ml NBT, and 1.0 mg/ml -NADPH for 30-60 min. After fixation with a paraformaldehyde solution, the enzyme NADPH-d that remains active is
a NOS coenzyme. In selected sections, ChAT immunochemistry was combined
with the NADPH-d reactions (for example, see Fig. 8).
After immunocytochemistry, selected sections were counterstained by
Pyronin Y.
Data analysis
Histological sections were examined using an Olympus BX60
microscope (Olympus Optical, Tokyo, Japan). Photomicrographs for neuronal counting and illustrations were obtained by means of a digital
camera attached to the microscope and connected to a microcomputer with
Photoshop software (Adobe Systems, San Jose, CA). To determine soma
size, a 100× oil immersion objective lens was used. Stained neurons in
which the nucleolus was apparent were photographed, and their major and
minor soma diameters were measured as described previously (Morales et
al., 1999 ). The value for cell diameter in the present work is that of
the sum of the major and minor diameters divided by 2.
Preliminary observations indicated a considerable number of
Fos-immunoreactive cells in the Cun of AS-carbachol cats. Therefore, sections selected for analysis were located between posterior 0.9 and
2.1 encompassing this nucleus in its entirety (Berman, 1968 ). Ten
nonadjacent sections of the brainstem of each cat were used to count
Fos+ nuclei. The mean number of
Fos+ cells in the Cun nucleus per section
and per cat was calculated. The means for AS-carbachol and control
animals were compared using the Student's t test. The
following formula was used to express the percent increase in
number of neurons during AS-carbachol:
where AS and C are mean number of
Fos+ cells in AS-carbachol and control, respectively.
 |
RESULTS |
After carbachol microinjection, the experimental cats exhibited a
prolonged (1 hr 52 min ± 5 min) active sleep-like state (AS-carbachol).
Figure 1A illustrates
the pontomesencephalic region, which is the focus of the present
report. The boundaries of the Cun nucleus are the periaqueductal
gray medially, the inferior colliculus (IC) dorsally, and the
lateral lemniscus laterally. Ventrally, in its rostral portion, the Cun
nucleus is separated from the brachium conjunctivum by the lateral
portion of the PPT and, in its caudal portion, by the lateral
parabrachial subnuclei (Fulwiler and Saper, 1984 ; Rye et al., 1987 ;
Steriade and McCarley, 1990 ).

View larger version (49K):
[in this window]
[in a new window]
|
Figure 1.
c-fos expression in neurons of the
Cun nucleus in an experimental cat. A, Diagram of a
brainstem section of an experimental animal to show the location of the
Cun nucleus and surrounding structures. B, The
photomicrograph was taken at low magnification (10×) to illustrate the
concentration of Fos+ nuclei in this nucleus. The
histological section in the photomicrograph was processed for both ChAT
and Fos immunostaining. Neurons expressing ChAT are those dorsal to the
brachium conjunctivum; Fos-labeled nuclei are located dorsal to this
population of cells. c-fos-expressing cells were not
ChAT-labeled neurons, and ChAT-labeled neurons did not express
c-fos. The fibers of the IV cranial nerve were
transversely cut and can be observed in the top left
corner of the photomicrograph. C, Higher
magnification photomicrograph of the ChAT-labeled cells.
D, Higher magnification photomicrograph of the
Fos+ cells. Scale bars: B, 100 µm;
C, D, 60 µm. bc,
Brachium conjunctivum; PAG, periaqueductal gray;
IVn, trochlear nerve.
|
|
The photomicrograph in Figure 1B was taken from a
brainstem section from an experimental cat. The tissue was processed
for both ChAT and Fos immunostaining. Selected areas of this section (dashed rectangles) are illustrated at higher magnification
in C and D. ChAT immunoreactivity appears as a
cytoplasmic stain, and Fos immunoreactivity appears as a dark nuclear
stain. Numerous Fos+ nuclei can be
observed ventral to the IC and lateral to the fibers of the trochlear
nerve (Fig. 1B). A group of ChAT-positive cells lies
between the Fos+ population and the
brachium conjunctivum. A photomicrograph of these cells is presented at
higher magnification in Figure 1C. This cholinergic
population corresponds to the lateral part of the PPT (Jones and
Beaudet, 1987 ; Rye et al., 1987 ; Vincent and Reiner, 1987 ). The nuclei
of these cholinergic cells, which are not part of the Cun nucleus, did
not contain detectable amounts of the Fos protein. Maloney et al.
(1999) have described a 22% increase in the number of
Fos+ cholinergic neurons of the LDT-PPT
under conditions of AS recovery in rats. However, within the lateral
PPT, which encompasses the cholinergic cells illustrated in the diagram
and in the photomicrograph in Figure 1, these authors did not describe
a significant difference in Fos+
cholinergic neurons, which is in agreement with our present results.
The photomicrographs in Figure 2 were
taken at high magnification from tissue immunostained for the Fos
protein and counterstained to reveal the morphology of neuronal cell
bodies. The column on the left is from an
experimental cat and depicts Fos+ neurons.
The column on the right is from a control cat.
Cun neurons were found to be small (mean soma diameter of 14 ± 1.6 µm), fusiform or polygonal in shape, with a relatively large
nucleus and a single nucleolus. The arrows indicate neurons
with a triangular profile. With respect to their morphology, the Cun
neurons observed in our study were similar to those described by
Gioia and Bianchi (1987) in the cat and Rye et al. (1987) in the
rat.

View larger version (120K):
[in this window]
[in a new window]
|
Figure 2.
Examples of Cun nucleus neurons illustrating the
morphology of their cell bodies. Photomicrographs in the left
column illustrate neurons from a section of an experimental
animal that was processed for Fos immunostaining and counterstained by
Pyronin Y. Right column, as left
column, but with tissue obtained from a control animal.
The arrows point to triangular cell bodies. The rest of
the cell bodies exhibit a fusiform shape. Note that the cytoplasm
surrounding the nucleus of the neurons is very thin. Scale bars, 5 µm.
|
|
In AS-carbachol cats, Cun neurons expressing c-fos were
observed along the rostrocaudal extent of this structure (Fig.
3). Figure
4 summarizes our results. The number of
Fos+ cells per section in AS-carbachol
cats was 96.4 ± 10.5 (mean ± SEM) on the ipsilateral side
and 78.2 ± 12.3 on the contralateral side; in control cats, it
was 12.5 ± 2.0. There was a 671% increase in the number of
c-fos-expressing cells on the ipsilateral side and a 523%
increase on the contralateral side in AS-carbachol cats when compared
with control animals. In both cases, the differences were statistically
significant (p < 0.0001). The absolute mean value of Fos+ cells in AS-carbachol cats
was larger ipsilaterally than contralaterally to the injection side.
However, the p value, although low (<0.09), did not reach
statistical significance. In control cats, there were no statistical
differences in the number of Fos+ cells
between sides of the brainstem.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 3.
Localization of Fos-labeled neurons of the Cun
nucleus at four levels of the cat brainstem. The schematics are from an
experimental animal and correspond to coronal sections of the brainstem
taken at 540 µm intervals. The most posterior section corresponds
approximately to posterior 2.1 (Berman, 1968 ). The
circles represent Fos+ nuclei; tissue
was obtained immediately after a long episode of AS-carbachol and
processed for Fos protein immunostaining and counterstained by Pyronin
Y. Aq, Aqueduct; bc, brachium
conjunctivum; bp, brachium pontis; LLD,
dorsal nucleus of the lateral lemniscus; ml, medial
lemniscus; P, pyramidal tract; PAG,
periaqueductal gray; ll, lateral lemniscus.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Figure 4.
c-fos expression in control and
experimental cats. The bar chart represents the mean of the average
number of Fos+ neurons per section per cat within
the Cun nucleus. These data were obtained from five experimental and
six control cats. Mean ± SEM values: control, 12.5 ± 2.0;
AS-carbachol, ipsilateral, 96.4 ± 10.5; AS-carbachol,
contralateral, 78.2 ± 12.3 (* and +, p < 0.0001).
|
|
Neurotransmitter phenotype
Figures
5-8
are examples of experiments in which Fos immunocytochemistry was
combined with different techniques to label glutamatergic, GABAergic,
cholinergic, or NOS-NADPH-d containing neurons.

View larger version (88K):
[in this window]
[in a new window]
|
Figure 5.
Fos+ Cun nucleus neurons did
not exhibit glutamate-like immunoreactivity. The histological sections
in the photomicrographs were processed for both glutamate and Fos
immunostaining. A is a photomicrograph of the Cun
nucleus, B is from the inferior colliculus, and
C is from mesencephalic trigeminal neurons. Scale bars:
A, 50 µm; B, C, 25 µm.
|
|

View larger version (48K):
[in this window]
[in a new window]
|
Figure 6.
Top Left, GABAergic neurons in the Cun
nucleus. A is a diagram of one section immunostained for
both GABA and Fos. Open circles represent
GABA+, Fos neurons;
filled circles represent Fos+,
GABA neurons; and large circles
with a dot represent double-labeled
GABA+, Fos+ neurons. The
histological sections were obtained from an experimental cat and
processed for both GABA and Fos immunostaining in B and
for GAD and Fos immunostaining in C and
D. B and C are examples of
putative GABAergic neurons that express c-fos. In
D are examples of GAD+ neurons that
do not express c-fos. Scale bars, 25 µm.
bc, Brachium conjunctivum; IV, fourth
ventricle; Vt, mesencephalic tract.
Figure 7.
Top Right, Differences between the
NADPH-d-reactive neurons in the Cun nucleus and those within the PPT.
The histological section from which these photomicrographs were taken
was obtained from an experimental cat, processed for Fos protein
immunostaining and treated to reveal NADPH-d activity. The
top photomicrograph is from the Cun nucleus, the
bottom one is from the PPT. Note the differences in
size, shape, and intensity of the cytoplasmic stain between both types
of cells. The Cun cells are Fos+. Scale bar, 15 µm.
Figure 8.
Bottom, c-fos expression in a
subpopulation of neurons of the nucleus Cun displaying NADPH-d
activity. A illustrates the location of these neurons
(shaded area) in a coronal section at the level of the
decussation of the fibers of the trochlear nerve (IVn;
arrow). B, Photomicrograph of a section
treated to reveal neurons displaying NADPH-d activity. This section was
also processed for Fos immunostaining and counterstained.
C is an expanded view of this region of the Cun nucleus.
Note the presence of numerous c-fos-expressing
NADPH-d+ neurons. The C' inset shows
a neuron of this region (arrowhead) at greater
magnification. D is an expanded view of the LDT nucleus
containing typical NADPH-d+ cholinergic neurons.
E-G, These were taken from sections that were processed
for ChAT immunostaining and treated to determine those neurons
displaying NADPH-d activity. E is a photomicrograph of a
subpopulation of Cun nucleus neurons; these neurons were pale
blue and did not exhibit ChAT immunostaining. In
F are two PPT neurons; the arrowhead
points to a brown neuron that exhibits pure ChAT
immunostaining and not NADPH-d activity. The arrow
points to a blue-brown cell that displays both ChAT
immunostaining and NADPH-d activity. G corresponds to
the region of the LDT; the arrowheads point to clearly
double-labeled neurons. H, I, These
photomicrographs were taken from the same section, which was processed
for both Fos and NOS immunostaining. In H, a Cun neuron
that expresses c-fos and displays NOS reactivity is
shown. I shows an NOS-immunoreactive,
Fos LDT neuron. Scale bars: C', 20 µm; D, 40 µm (also applies to C);
E-G, 40 µm; H, I, 5 µm. bc, Brachium conjunctivum.
|
|
As shown in the example presented in Figure 5A,
Fos+ cells in the Cun nucleus did not show
glutamate-like immunoreactivity. Glutamate-like reactivity was,
however, observed in structures contained in the same or adjacent
brainstem sections, for example in the IC or in the mesencephalic
trigeminal (Mes-V) nucleus as shown in Figure 5, B and
C. The observation that neurons in the Cun nucleus did not
display glutamate immunoreactivity was unexpected. This issue will be
addressed in Discussion. In addition, these neurons did not exhibit
serotonergic, catecholaminergic, or glycinergic immunoreactivity.
GABAergic neurons were identified by using either an antibody directed
at a GABA-conjugated protein or one directed at GAD. In Figure 6 are
examples of these GABAergic neurons in the Cun nucleus. The diagram in
Figure 6A illustrates the distribution of these cells
[open circles are GABA+,
Fos-negative (Fos ) neurons;
dotted circles are GABA+,
Fos+ neurons; filled circles
are Fos+,
GABA cells]. GABAergic cells had a
tendency to cluster close to the ventral border of the IC. The great
majority (92%) of GABAergic cells did not express c-fos.
The fact that the Cun nucleus contains GABAergic cells is in agreement
with the observations of others (Mugnaini and Oertel, 1985 ; Appell and
Behan, 1990 ).
The results obtained with NADPH-d histochemistry and/or with NOS, ChAT,
and Fos immunostaining are shown in Figures 7 and 8. Within the Cun
nucleus, there was a population of NADPH-d-containing neurons. The
photomicrographs in Figure 7 are two examples of these Cun neurons and
an example of a NADPH-d positive neuron that belongs to the cholinergic
population of the pontine tegmentum. Note the marked morphological
differences between these two types of cells.
During AS-carbachol, 50% of the NADPH-d-containing Cun neurons
expressed c-fos compared with only 1% in control, awake
cats. The shaded area in Figure 8A
indicates the location of these neurons within the central portion of
the Cun nucleus. This population was concentrated in the caudal portion
of this nucleus, at approximately posterior 2.1 (Berman, 1968 ), the
level of the crossing fibers of the IV nerve (arrow). The
photomicrograph in B is a low-magnification (10×)
presentation of a section processed with NBT to determine NADPH-d
activity. Although it is not evident at this magnification, this
section was also treated previously to detect c-fos
expression. NADPH-d activity was visualized as a blue
cytoplasmic stain. In this section, both the NADPH-d reactive
population in the Cun nucleus and that in the LDT are visible. A view
at higher magnification of each of these two regions is illustrated in
C and D, respectively.
Numerous double-labeled Fos+, NADPH-d
reactive cells may be observed in Figure 8C. These cells
were small (mean soma diameter of 14.5 ± 1.7 µm), and most of
them had a fusiform shape (see C' inset and
H). For comparison, the typical large (mean soma diameter of 26 ± 4.6 µm), polygonal NADPH-d-reactive cells of the LDT are shown in Figure 8D. Cholinergic LDT-PPT
neurons are also NADPH-d-reactive (Vincent et al., 1986 ), whereas
NADPH-d-reactive cells in the Cun nucleus were not found to be
cholinergic. Examples of different regions in a section treated to
examine both ChAT and NADPH-d are shown in Figure
8E-G. With this technique, the cytoplasmic
blue product of the NADPH-d NBT reaction mixes with the
cytoplasmic brown reaction product of ChAT
immunohistochemistry. It can be observed in Figure 8E
that the Cun NADPH-d positive cells were pale blue but
ChAT-negative. In contrast, the majority of ChAT-positive cells within
the LDT-PPT displayed NADPH-d activity. The arrowhead in
Figure 8F points to a cholinergic cell that does not
display signs of NADPH-d activity, whereas the arrow points to a clearly double-labeled cell. All six cells illustrated in Figure
8G appeared as double-labeled cells when directly examined under the microscope. The arrowheads point to three of these
cells, which, in the photomicrograph, are clearly visualized as
NADPH-d-reactive and ChAT-positive.
Immunohistochemistry demonstrated that NADPH-d-containing
neurons also contained NOS. An example of a fusiform
Fos+ Cun neuron labeled by the NOS
antibody is shown in Figure 8H. For comparison, a LDT
neuron positive for NOS immunostaining is presented in Figure
8I. It is known that neurons that contain both NOS
and NADPH-d are able to produce NO; therefore, we refer to those
neurons that exhibit this particular kind of immunoreactive profile as
nitrergic neurons (Hope et al., 1991 ).
 |
DISCUSSION |
We suggest that the robust Fos immunoreactivity found in the
present study in Cun neurons during AS-carbachol reflects neuronal excitation related to this state. The Cun nucleus itself has not been
implicated before in AS processes, although in its immediate vicinity,
in the lateral PPT, the presence of PGO on neurons has been described
previously (Paré et al., 1990 ). Our findings indicate the need to
examine the role of the Cun nucleus in AS and related physiological processes.
Methodological considerations
Using the variables that were measured, the state induced by
carbachol is indistinguishable from normal AS, but it is not the
natural state (Morales et al., 1987 ; López-Rodríguez et al., 1995 ; Kohlmeier et al., 1996 ; Xi et al., 1997 ; Maloney et al.,
1999 ). AS-carbachol is of long duration, and it is therefore possible
that some of the neurons that express c-fos do so because of
an increase in their metabolism rather than because of an increase in
their firing alone. However, the pharmacologically induced AS state was
used to allow enough time for the Fos protein to accumulate to
detectable levels (Yamuy et al., 1993 ; Shiromani et al., 1995 ). On this
issue, as well as on that of the potential caveats related to the use
of c-fos expression, we refer the reader to previous works
(Dragunow and Faull, 1989 ; Herrera and Robertson, 1996 ; Chaudhuri,
1997 ; Maloney et al., 1999 ; Morales et al., 1999 ). It is unlikely that
c-fos expression reflects neuronal inhibition, because it
depends mostly on an increase in intracellular
Ca2+ concentration that occurs during
certain kinds of excitatory synaptic transmission. In addition, cells
such as motoneurons, which are subjected to sustained postsynaptic
inhibition during AS, do not express c-fos during this state
(Yamuy et al., 1993 ). Therefore, our interpretation of the data is
based on the assumption that c-fos expression reflects
neuronal activation.
Neurotransmitter phenotype
Cuneiform neurons are not a homogeneous population of cells. We
observed three different types of cells in this nucleus. There was a
population of GABAergic cells, most of which did not express c-fos during AS-carbachol, and therefore do not appear to be
specifically active during the state. Two different populations of
neurons did express c-fos. In one of these
Fos+ populations, we were unable to
identify a neurotransmitter. The other
Fos+ population consisted of nitrergic
neurons. Of equivalent importance to these positive results is the
absence of cholinergic, catecholaminergic, glycinergic, or serotonergic
neurons in this structure. Several peptides have been shown to exist in
the Cun nucleus (e.g., substance P, enkephalins, and corticotropin
releasing factor) (Beitz, 1982 ; Sakanaka et al., 1987 ). Because
peptides are usually colocalized with classical neurotransmitters, it
is possible that cells expressing c-fos are also peptidergic.
The nature of the neurotransmitter in one of the populations of
Fos+ Cun neurons remains unknown. Although
we did not detect glutamate-like reactivity in their cell bodies, there
is evidence of excitatory amino acid-containing projections from this
nucleus that could be glutamatergic (Beitz, 1989 ; Beart et al., 1990 ;
Richter and Behbehani, 1991 ). A lack of sensitivity of our
immunocytochemical technique is not likely to be the reason why
glutamate immunoreactivity was not detected in Cun cells because
glutamate-like reactivity was observed in known glutamatergic cells in
the inferior colliculus and in the Mes-V nucleus in the same and
adjacent sections (Fig. 5). Results from immunocytochemistry examining
excitatory amino acids are difficult to interpret, particularly when
one is confronted by the lack of staining in cell somas (Beitz, 1990 ;
Storm-Mathisen and Ottersen, 1990 ). Glutamatergic neurons may exhibit
lower levels of glutamate-like immunoreactivity in their cell bodies
than in their axon terminals (Storm-Mathisen and Ottersen, 1990 ;
Quaglino et al., 1999 ). Therefore, it is possible that Cun cells use
glutamate as their neurotransmitter but that their perikarya do not
display significant levels of immunoreactivity. Alternatively,
aspartate rather than glutamate may be used by Cun cells as a
neurotransmitter (McGeer et al., 1987 ; Robinson and Coyle, 1987 ).
Nitrergic Cun neurons should not be confused with the cholinergic cells
of the LDT-PPT that also contain NOS and display NADPH-d activity
(Vincent et al., 1986 ) for the following reasons. Cun neurons did not
show immunoreactivity for ChAT, they were smaller than cholinergic
cells in the LDT-PPT (14 ± 0.24 vs 26 ± 0.58 µm,
respectively; p < 0.0001), and their morphology was
different (Figs. 7, 8). The fact that these Cun neurons are nitrergic,
but not cholinergic, raises the question as to the conventional
neurotransmitter that they use.
Fifty percent of the nitrergic Cun neurons expressed c-fos
during AS-carbachol. To the best of our knowledge, nothing is known about their connections and functions. However, based on our present findings, it would be expected that their cell bodies and their axon
terminals produce NO during AS and that this molecule modulates the
activity of the targets for Cun neurons. In this regard, the Cun
nucleus is the origin of ascending and descending pathways. Its
ascending fibers project to the hypothalamus, to the central amygdala,
and to several thalamic nuclei (parafascicular, centromedian, and
centrolateral) (Edwards and de Olmos, 1976 ; Zemlan and Behbehani, 1988 ;
Korte et al., 1992 ). In the lateral geniculate nucleus (LGN), NO is
produced in greater amounts during AS (Williams et al., 1997 ). LGN
neurons are modulated by NO (Pape and Mager, 1992 ), likely produced in
the axon terminals from LDT-PPT neurons. By analogy, we suggest that
the NO that would be produced by cuneiform axon terminals modulates the
activity of other thalamic nuclei during AS. Descending Cun fibers
mainly innervate the nucleus raphe magnus (RM) and the giganto- and
magno-cellularis nuclei (NRGC and NMC, respectively) (Edwards, 1975 ;
Zemlan and Behbehani, 1988 ; Bernard et al., 1989 ). Within RM, NRGC, and
NMC nuclei, we have found larger numbers of
Fos+ neurons during AS-carbachol than
during wakefulness and have suggested that they are activated during
AS-carbachol (Yamuy et al., 1993 , 1995 ; Morales et al., 1999 ). Maloney
et al. (1999) , in turn, have reported an increase in the number of
GABAergic neurons within the RM during the recovery of AS in rats. Cun
Fos+ neurons could be one of the sources
of the activation of cells within these nuclei, and NO may modulate the
behavior of their neurons.
Relevance to sleep physiology
Convincing evidence has been presented in previous studies
indicating that NO produced by LDT-PPT cholinergic neurons is involved in the modulation of sleep and waking states, as well as in the release
of acetylcholine in the rostral pontine tegmentum (Datta et al., 1997 ;
Leonard and Lydic, 1997 ; Hars, 1999 ). In the present study, we found
that a subpopulation of Cun neurons could also be an important source
of NO produced during AS. However, it is not possible to assign a
single physiological role to Cun neurons during AS because of the
heterogeneity of functions in which the Cun nucleus has been
implicated. In this regard, this nucleus is part of the mesencephalic
locomotor region (Grillner, 1981 ; Garcia-Rill and Skinner, 1988 ; Mori
et al., 1989 ). Interestingly, animals under picrotoxin-induced
locomotor activity display an increase in c-fos-expressing
cells in this nucleus (Brudzynski and Wang, 1996 ). However, compared
with the number of Fos+ cells observed in
the present work, the number of c-fos-expressing cells
during induced locomotion is two orders of magnitude lower. In other
studies, the Cun nucleus has been considered important in the
integration of cardiovascular-autonomic functions (Korte et al., 1992 ;
Lam et al., 1996 ). The Cun nucleus may be also involved in defensive or
stress-related behaviors (Korte et al., 1992 ), a condition during which
there is also evidence of increased c-fos expression
(Kollack-Walker et al., 1997 ).
The activation of the Cun neurons during AS may be involved in three
processes that take place during this state. The first, that was
discussed above, relates to the possible regulation of thalamic neurons
during AS. The second is antinociception. It was only recently that
this process was demonstrated to occur after the administration of
cholinomimetic substances in the pons and during cholinergically
induced AS (Kshatri et al., 1998 ). The Cun nucleus is a component of
the descending anti-nociceptive system (Dostrovsky et al., 1983 ;
Katayama et al., 1984 ; Zemlan and Behbehani, 1988 ; Richter and
Behbehani, 1991 ). The RM, which is also part of this system and
exhibits strong c-fos expression during AS-carbachol (see
above), is heavily innervated by Cun fibers (Leung and Mason, 1999 ;
Mason, 1999 ). It is likely that cholinergic activation of the rostral
pontine tegmentum during AS results in antinociception caused by
the subsequent activation of the above mentioned structures.
The third process that may be regulated by Cun activation during AS is
motor inhibition. Electrical stimulation of the Cun nucleus elicits
suppression of muscular tone and somatic reflexes (Mileikovsky et al.,
1989 , 1990 ; Mileikovsky and Nozdrachev, 1997 ). These effects, we
suggest, may be mediated by premotor inhibitory neurons within the
ventromedial medulla (Morales et al., 1999 ). The ventromedial medulla
is one of the principal targets of Cun fibers. It is possible that Cun
terminals modulate the activity of premotor neurons during AS through a
synergistic mechanism that involves excitatory neurotransmitters and
modulatory nitrergic actions.
 |
FOOTNOTES |
Received Nov. 29, 1999; revised Feb. 10, 2000; accepted Feb. 17, 2000.
This work was supported by United States Public Health Service Grants
NS 23426, NS09999, and MH 43362. We thank Gerardo Morales for his
technical assistance.
Correspondence should be addressed to Dr. Francisco Morales, Department
of Physiology, University of California at Los Angeles School of
Medicine, Los Angeles, CA 90095. E-mail: fmorales{at}ucla.edu.
 |
REFERENCES |
-
Appell PP,
Behan M
(1990)
Sources of subcortical GABAergic projections to the superior colliculus in the cat.
J Comp Neurol
302:143-158[Web of Science][Medline].
-
Baghdoyan HA,
Rodrigo-Angulo ML,
McCarley RW,
Hobson JA
(1987)
A neuroanatomical gradient in the pontine tegmentum for the cholinoceptive induction of desynchronized sleep signs.
Brain Res
414:245-261[Web of Science][Medline].
-
Baghdoyan HA,
Lydic R,
Callaway CW,
Hobson JA
(1989)
The carbachol-induced enhancement of desynchronized sleep is dose dependent and antagonized by centrally administered atropine.
Neuropsychopharmacology
2:67-69[Web of Science][Medline].
-
Beart PM,
Summers RJ,
Stephenson JA,
Cook CJ,
Christie MJ
(1990)
Excitatory aminoacid projections to the periaqueductal gray in the rat: a retrograde transport study utilizing D[3H]aspartate and [3H]GABA.
Neuroscience
34:163-176[Medline].
-
Beitz AJ
(1982)
The nuclei of origin of brain stem enkephalin and substance P projections to the rodent nucleus raphe magnus.
Neuroscience
7:2753-2768[Web of Science][Medline].
-
Beitz AJ
(1989)
Possible origin of glutamatergic projections to the midbrain periaqueductal gray and deep layers of the superior colliculus of the rat.
Brain Res Bull
23:25-35[Medline].
-
Beitz AJ
(1990)
Relationship of glutamate and aspartate to the periaqueductal gray-raphe magnus projection: analysis using immunocytochemistry and microdialysis.
J Histochem Cytochem
38:1755-1765[Abstract].
-
Berman AL
(1968)
In: The brainstem of the cat. A cytoarchitectonic atlas with stereotaxic coordinates. Madison, WI: University of Wisconsin.
-
Bernard JF,
Peschansky M,
Besson JM
(1989)
Afferents and efferents of the cuneiform nucleus: an anatomical study with reference to pain transmission.
Brain Res
490:181-185[Medline].
-
Brudzynski SM,
Wang D
(1996)
C-Fos immunohistochemical localization of neurons in the mesencephalic locomotor region in the rat brain.
Neuroscience
75:793-803[Web of Science][Medline].
-
Capece ML,
Baghdoyan HL,
Lydic R
(1998)
Carbachol stimulates (35S) guanylyl 5'-(
-thio)-triphosphate binder in REM sleep-related brain stem nuclei of the rat.
J Neurosci
18:3779-3785[Abstract/Free Full Text]. -
Chaudhuri A
(1997)
Neural activity mapping with inducible transcription factors.
NeuroReport
8:v-ix[Medline].
-
Datta S,
Patterson EH,
Siwek DF
(1997)
Endogenous and exogenous nitric oxide in the pedunculopontine tegmentum induces sleep.
Synapse
27:69-78[Web of Science][Medline].
-
Dostrovsky JO,
Shah Y,
Gray BG
(1983)
Descending inhibitory influences from periaqueductal gray, nucleus raphe magnus, and adjacent reticular formation. II. Effects on medullary dorsal horn nociceptive and nonnociceptive neurons.
J Neurophysiol
49:948-960[Abstract/Free Full Text].
-
Dragunow M,
Faull R
(1989)
The use of c-fos as a metabolic marker in neuronal pathway tracing.
J Neurosci Methods
29:261-265[Web of Science][Medline].
-
Edwards SB
(1975)
Autoradiographic studies of the projections of the midbrain reticular formation: descending projections of nucleus cuneiformis.
J Comp Neurol
161:341-358[Web of Science][Medline].
-
Edwards SB,
de Olmos JS
(1976)
Autoradiographic studies of the projections of the midbrain reticular formation: ascending projections of nucleus cuneiformis.
J Comp Neurol
165:417-431[Web of Science][Medline].
-
Fulwiler CE,
Saper CB
(1984)
Subnuclear organization of the efferent connections of the parabrachial nucleus in the rat.
Brain Res Rev
7:229-259.
-
Garcia-Rill E,
Skinner RD
(1988)
Modulation of rhythmic function in the posterior midbrain.
Neuroscience
27:639-654[Web of Science][Medline].
-
George R,
Haslett WL,
Jenden DJ
(1964)
A cholinergic mechanism in the brainstem reticular formation: induction of paradoxical sleep.
Int J Neuropharmacol
3:541-552.
-
Gioia M,
Bianchi R
(1987)
The cytoarchitecture of the nucleus cuneiformis. A Nissl and Golgi study.
J Anat
155:165-176[Medline].
-
Grillner S
(1981)
Control of locomotion in bipeds, tetrapeds and fish.
In: Handbook of physiology. The nervous system, Vol 2, Motor control (Brookhart JM,
Mountcastle VB,
Brooks VB,
eds), pp 1179-1236. Bethesda, MD: American Physiology Society.
-
Hars B
(1999)
Endogenous nitric oxide in the rat pons promotes sleep.
Brain Res
816:209-219[Web of Science][Medline].
-
Herrera DG,
Robertson HA
(1996)
Activation of c-fos in the brain.
Prog Neurobiol
50:83-107[Web of Science][Medline].
-
Hobson JA
(1992)
Sleep and dreaming: induction and mediation of REM sleep by cholinergic mechanisms.
Curr Opin Neurobiol
2:759-763[Medline].
-
Hope BT,
Michael GJ,
Knigge KM,
Vincent SR
(1991)
Neuronal NADPH diaphorase is a nitric oxide synthase.
Proc Nat Acad Sci USA
88:2811-2814[Abstract/Free Full Text].
-
Jones BE
(1991)
Paradoxical sleep and its chemical/structural substrates in the brain.
Neuroscience
40:637-656[Web of Science][Medline].
-
Jones BE,
Beaudet A
(1987)
Distribution of acetylcholine and catecholamine neurons in the cat brain stem studied by choline acetyltransferase and tyrosine hydroxilase immunohistochemistry.
J Comp Neurol
261:15-32[Web of Science][Medline].
-
Katayama Y,
DeWitt DS,
Becker DP,
Hayes RL
(1984)
Behavioral evidence for a cholinoceptive pontine inhibitory area: descending control of spinal motor output and sensory input.
Brain Res
296:241-264[Web of Science][Medline].
-
Kohlmeier KA,
López-Rodríguez F,
Liu RH,
Morales FR,
Chase MH
(1996)
State dependent phenomena in cat masseter motoneurons.
Brain Res
722:30-38[Web of Science][Medline].
-
Kollack-Walker S,
Watson SJ,
Akil H
(1997)
Social stress in hamsters: defeat activates specific neurocircuits within the brain.
J Neurosci
17:8842-8855[Abstract/Free Full Text].
-
Korte SM,
Jaarsma D,
Luiten PG,
Bohus B
(1992)
Mesencephalic cuneiform nucleus and its ascending and descending projections serve stress-related cardiovascular responses in the rat.
J Auton Nerv Syst
41:157-176[Web of Science][Medline].
-
Kshatri AM,
Baghdoyan HA,
Lydic R
(1998)
Cholinomimetics, but not morphine, increase antinociceptive behavior from pontine reticular regions regulating rapid-eye-movement sleep.
Sleep
21:677-685[Web of Science][Medline].
-
Lam W,
Gundlach AL,
Verberne AJ
(1996)
Increased nerve growth factor inducible-A gene and c-fos messenger RNA levels in the rat midbrain and hindbrain associated with the cardiovascular response to electrical stimulation of the mesencephalic cuneiform nucleus.
Neuroscience
71:193-211[Medline].
-
Leonard TO,
Lydic R
(1997)
Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate.
J Neurosci
17:774-785[Abstract/Free Full Text].
-
Leung CG,
Mason P
(1999)
Physiological properties of raphe magnus neurons during sleep and waking.
J Neurophysiol
81:584-595[Abstract/Free Full Text].
-
López-Rodríguez F,
Kohlmeier K,
Yamuy J,
Morales FR,
Chase MH
(1995)
Muscle atonia can be induced by carbachol injections into the nucleus pontis oralis in cats anesthetized with a-chloralose.
Brain Res
699:201-207[Web of Science][Medline].
-
Maloney KJ,
Mainville L,
Jones BE
(1999)
Differential c-Fos expression in cholinergic, monoaminergic, and GABAergic cell groups of the pontomesencephalic tegmentum after paradoxical sleep deprivation and recovery.
J Neurosci
19:3057-3072[Abstract/Free Full Text].
-
Mason P
(1999)
Central mechanisms of pain modulation.
Curr Opin Neurobiol
9:436-441[Web of Science][Medline].
-
McGeer PL,
Eccles JC,
McGeer EG
(1987)
Putative excitatory neurons: glutamate and Aspartate.
In: Molecular neurobiology of the mammalian brain. Ed 2 (McGeer PL,
Eccles JC,
McGeer EG,
eds), pp 175-196. New York: Plenum.
-
Merchant-Nancy H,
Vázquez J,
Aguilar-Roblero R,
Drucker-Colin R
(1992)
C-fos proto-oncogene changes in relation to REM sleep duration.
Brain Res
579:342-346[Medline].
-
Mileikovsky BY,
Nozdrachev AD
(1997)
Electrophysiological analysis of interaction between the pons and medulla, the brainstem inhibitory areas.
Fiziol Zh SSSR Im I M Sechenova
83:57-63.
-
Mileikovsky BY,
Verevkina SV,
Nozdrachev AD
(1989)
The participation of the inhibitory locomotor system of the brain stem in regulating pain sensitivity.
Fiziol Zh SSSR Im I M Sechenova
75:1051-1056[Medline].
-
Mileikovsky BY,
Verevkina SV,
Nozdrachev AD
(1990)
The central neurophysiological mechanisms in the regulation of inhibition.
Fiziol Zh SSSR Im I M Sechenova
76:289-294[Medline].
-
Morales FR,
Engelhardt JK,
Soja PJ,
Pereda AE,
Chase MH
(1987)
Motoneuron properties during motor inhibition produced by microinjection of carbachol into the pontine reticular formation of the decerebrate cat.
J Neurophysiol
57:1118-1129[Abstract/Free Full Text].
-
Morales FR,
Sampogna S,
Yamuy J,
Chase MH
(1999)
c-Fos expression in brainstem premotor interneurons during cholinergically-induced active sleep in the cat.
J Neurosci
19:9508-9518[Abstract/Free Full Text].
-
Mori S,
Sakamoto T,
Ohta Y,
Takakusaki K,
Matsuyama K
(1989)
Site-specific postural and locomotor changes evoked in awake, freely moving intact cats by stimulating the brainstem.
Brain Res
505:66-74[Web of Science][Medline].
-
Mugnaini E,
Oertel WH
(1985)
An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry.
In: Handbook of chemical neuroanatomy, Vol 4, GABA and neuropeptides in the CNS, Pt I (Bjorklund A,
Hokfelt T,
eds). Amsterdam: Elsevier.
-
Pape HC,
Mager R
(1992)
Nitric oxide controls oscillatory activity in thalamocortical neurons.
Neuron
9:441-448[Web of Science][Medline].
-
Paré D,
Curró Dossi R,
Datta S,
Steriade M
(1990)
Brainstem genesis of reserpine-induced ponto-geniculo-occipital waves: an electrophysiological and morphological investigation.
Exp Brain Res
81:533-544[Web of Science][Medline].
-
Quaglino E,
Giustetto M,
Panzanelli P,
Cantino D,
Fasolo A,
Sassoè Pognetto M
(1999)
Immunocytochemical localization of glutamate and gamma-aminobutyric acid in the accessory olfactory bulb of the rat.
J Comp Neurol
408:61-72[Web of Science][Medline].
-
Richter RC,
Behbehani MM
(1991)
Evidence for glutamic acid as a possible neurotransmitter between the mesencephalic nucleus cuneiformis and the medullary nucleus raphe magnus in the lightly anesthetized rat.
Brain Res
544:279-286[Web of Science][Medline].
-
Robinson MB,
Coyle JT
(1987)
Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application.
FASEB J
1:446-455[Abstract].
-
Rye DB
(1997)
Contributions of the pedunculopontine region to normal and altered REM sleep.
Sleep
20:757-788[Web of Science][Medline].
-
Rye DB,
Saper CB,
Lee HJ,
Wainer BH
(1987)
Pedunculopontine tegmental nucleus of the rat: cytoarchitecture, cytochemistry and some extrapyramidal connections of the mesopontine tegmentum.
J Comp Neurol
259:483-528[Web of Science][Medline].
-
Sakai K
(1988)
Executive mechanisms of paradoxical sleep.
Arch Ital Biol
126:239-257[Web of Science][Medline].
-
Sakanaka M,
Shibasaki T,
Lederis K
(1987)
Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method.
J Comp Neurol
260:256-298[Web of Science][Medline].
-
Shiromani JP,
Kilduff TS,
Bloom FE,
McCarley RW
(1992)
Cholinergically induced REM sleep triggers Fos-like immunoreactivity in dorsolateral pontine regions associated with REM sleep.
Brain Res
580:351-357[Web of Science][Medline].
-
Shiromani JP,
Malik M,
Winston S,
McCarley RW
(1995)
Time course of fos-like immunoreactivity associated with cholinergic induced REM sleep.
J Neurosci
15:3500-3508[Abstract].
-
Shuman SL,
Capece ML,
Baghdoyan HL,
Lydic R
(1995)
Pertussis toxin-sensitive G proteins mediate carbachol-induced REM sleep and respiratory depression.
Am J Physiol
269:R308-R317[Abstract/Free Full Text].
-
Siegel JM
(1994)
Brainstem mechanisms generating REM sleep.
In: Principles and practice of sleep medicine (Kryger MH,
Roth T,
Dement WC,
eds), pp 125-144. Philadelphia: Saunders.
-
Steriade M,
McCarley RW
(1990)
In: Brainstem control of wakefulness and sleep (Steriade M, McCarley RE, eds). New York: Plenum.
-
Storm-Mathisen J,
Ottersen OP
(1990)
Immunocytochemistry of glutamate at the synaptic level.
J Histochem Cytochem
38:1733-1743[Abstract].
-
Vanni-Mercier G,
Sakai K,
Lin JS,
Jouvet M
(1989)
Mapping of cholinoceptive brainstem structures responsible for the generation of paradoxical sleep in the cat.
Arch Ital Biol
127:133-164[Web of Science][Medline].
-
Vincent SR,
Reiner PB
(1987)
The immunohistochemical localization of choline acetyltransferase in the cat brain.
Brain Res Bull
18:371-415[Web of Science][Medline].
-
Vincent SR,
Satoh K,
Armstrong DM,
Panula P,
Vale W,
Fibiger HC
(1986)
Neuropeptides and NADPH-diaphorase activity in the ascending cholinergic reticular system of the rat.
Neuroscience
17:167-182[Web of Science][Medline].
-
Williams JA,
Vincent SR,
Reiner PB
(1997)
Nitric oxide production in rat thalamus changes with behavioral state, local depolarization, and brainstem stimulation.
J Neurosci
17:420-427[Abstract/Free Full Text].
-
Xi MC,
Liu RH,
Yamuy J,
Morales FR,
Chase MH
(1997)
Electrophysiological properties of lumbar motoneurons in the a-chloralose-anesthetized cat during carbachol-induced motor inhibition.
J Neurophysiol
78:129-136[Abstract/Free Full Text].
-
Yamuy J,
Mancillas JR,
Morales FR,
Chase MH
(1993)
c-Fos expression in the pons and medulla of the cat during carbachol-induced active sleep.
J Neurosci
13:2703-2718[Abstract].
-
Yamuy J,
Sampogna S,
López-Rodríguez F,
Luppi PH,
Morales FR,
Chase MH
(1995)
Fos and serotonin immunoreactivity in the raphe nuclei of the cat during carbachol-induced active sleep: a double-labeling study.
Neuroscience
67:211-223[Web of Science][Medline].
-
Yamuy J,
Sampogna S,
Morales FR,
Chase MH
(1998)
c-Fos expression in mesopontine noradrenergic and cholinergic neurons of the cat during carbachol-induced active sleep: a double-labeling study.
Sleep Res On-line
1:28-40[Medline].
-
Zemlan FP,
Behbehani MM
(1988)
Nucleus cuneiformis and pain modulation: anatomy and behavioral pharmacology.
Brain Res
453:89-102[Medline].
Copyright © 2000 Society for Neuroscience 0270-6474/00/2093319-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
V. Abudara, A. F. Alvarez, M. H. Chase, and F. R. Morales
Nitric Oxide as an Anterograde Neurotransmitter in the Trigeminal Motor Pool
J Neurophysiol,
July 1, 2002;
88(1):
497 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vazquez, R. Lydic, and H. A. Baghdoyan
The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Increases Basal Forebrain Acetylcholine Release during Sleep and Wakefulness
J. Neurosci.,
July 1, 2002;
22(13):
5597 - 5605.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|